Laurence Reid

Laurence Reid, PhD, is a biotech entrepreneur, company builder and advisor with 30 years of experience in the pharmaceutical and biotechnology industries. He previously served as CEO of Decibel Therapeutics, leading the company through its acquisition by Regeneron Pharmaceuticals, and as CEO of Warp Drive Bio through its merger with Revolution Medicines. Prior to that, Dr. Reid was Chief Business Officer at Alnylam Pharmaceuticals where he played a leadership role in shaping major alliances.  He currently serves on the boards of KalVista Pharmaceuticals, Metagenomi Therapeutics, and a number of private biotechnology companies. Dr. Reid holds a PhD in Biochemistry from King's College London.